1. Market Research
  2. > Pharmaceutical
  3. > Drug Discovery and Development Market Trends
  4. > Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014

Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014

Summary

GlobalData's clinical trial report, “Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014" provides data on the Human papillomavirus (HPV) Associated Cancer clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Human papillomavirus (HPV) Associated Cancer. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Human papillomavirus (HPV) Associated Cancer. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
- Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
- Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

- Understand the dynamics of a particular indication in a condensed manner
- Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
- Obtain discontinued trial listing for trials across the globe
- Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table Of Contents

Human papillomavirus (HPV) Associated Cancer Global Clinical Trials Review, H1, 2014
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Human papillomavirus (HPV) Associated Cancer 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Unaccomplished Trials of Human papillomavirus (HPV) Associated Cancer 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials 27
Prominent Drugs 29
Latest Clinical Trials News on Human papillomavirus (HPV) Associated Cancer 30
Nov 04, 2013: Merck's Investigational 9-valent HPV Vaccine, V503, Prevented 97 Percent of Cervical, Vaginal and Vulvar Pre-cancers Caused by Five Additional HPV Types, in Phase III Study 30
Apr 16, 2013: PDS Biotechnology's New Cancer Immunotherapy PDS0101 Set To Enter Clinical Trials 31
Feb 19, 2013: Advaxis Announces Brown University Oncology Group To Conduct Phase I/II Trial Of ADXS-HPV In Anal Cancer 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
GlaxoSmithKline plc 33
Clinical Trial Overview of GlaxoSmithKline plc 33
Transgene SA 34
Clinical Trial Overview of Transgene SA 34
Oryx GmbH and Co. KG 35
Clinical Trial Overview of Oryx GmbH and Co. KG 35
North Shore-Long Island Jewish Health System, Inc. 36
Clinical Trial Overview of North Shore-Long Island Jewish Health System, Inc. 36
Lee's Pharmaceutical Holdings Limited 37
Clinical Trial Overview of Lee's Pharmaceutical Holdings Limited 37
ISA Pharmaceuticals B.V. 38
Clinical Trial Overview of ISA Pharmaceuticals B.V. 38
EyeGene, Inc. 39
Clinical Trial Overview of EyeGene, Inc. 39
Clinical Trial Overview of Top Institutes / Government 40
The University of Hong Kong 40
Clinical Trial Overview of The University of Hong Kong 40
Sidney Kimmel Comprehensive Cancer Center 41
Clinical Trial Overview of Sidney Kimmel Comprehensive Cancer Center 41
Odense University Hospital 42
Clinical Trial Overview of Odense University Hospital 42
University Hospital, Essen 43
Clinical Trial Overview of University Hospital, Essen 43
Vanderbilt-Ingram Cancer Center 44
Clinical Trial Overview of Vanderbilt-Ingram Cancer Center 44
Eunice Kennedy Shriver National Institute of Child Health and Human Development 45
Clinical Trial Overview of Eunice Kennedy Shriver National Institute of Child Health and Human Development 45
Eastern Cooperative Oncology Group 46
Clinical Trial Overview of Eastern Cooperative Oncology Group 46
National Taiwan University Hospital 47
Clinical Trial Overview of National Taiwan University Hospital 47
National Cancer Institute 48
Clinical Trial Overview of National Cancer Institute 48
University of California, Davis 49
Clinical Trial Overview of University of California, Davis 49
Five Key Clinical Profiles 50
Appendix 118
Abbreviations 118
Definitions 118
Research Methodology 119
Secondary Research 119
About GlobalData 120
Contact Us 120
Disclaimer 120
Source 121

List of Tables
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region, 2014* 7
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2014* 10
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2014* 11
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries, 2014* 12
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Central and South America, Top Countries, 2014* 13
Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase, 2014* 20
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2014* 21
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Terminated Clinical Trials, 2014* 23
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Human papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2014* 25
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 28
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by GlaxoSmithKline plc, 2014* 33
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Transgene SA, 2014* 34
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Oryx GmbH and Co. KG, 2014* 35
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by North Shore-Long Island Jewish Health System, Inc., 2014* 36
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Lee's Pharmaceutical Holdings Limited, 2014* 37
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by ISA Pharmaceuticals B.V., 2014* 38
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by EyeGene, Inc., 2014* 39
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Hong Kong, 2014* 40
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Sidney Kimmel Comprehensive Cancer Center, 2014* 41
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Odense University Hospital, 2014* 42
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Essen, 2014* 43
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Vanderbilt-Ingram Cancer Center, 2014* 44
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eunice Kennedy Shriver National Institute of Child Health and Human Development, 2014* 45
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by Eastern Cooperative Oncology Group, 2014* 46
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2014* 47
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by National Cancer Institute, 2014* 48
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Davis, 2014* 49

List of Figures
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Region (%), 2014* 7
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2014* 8
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2014* 9
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2014* 10
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2014* 11
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2014* 12
Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, G7 Countries (%), 2014* 14
Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2014* 15
Human papillomavirus (HPV) Associated Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2014* 16
Proportion of Human papillomavirus (HPV) Associated Cancer to Oncology Clinical Trials, E7 Countries (%), 2014* 17
Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2014* 18
Human papillomavirus (HPV) Associated Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2014* 19
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2014* 20
Therapeutics, Global, Clinical Trials In Progress by Phase, 2014* 21
Human papillomavirus (HPV) Associated Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2014* 22
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2009-2013 24
Human papillomavirus (HPV) Associated Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2014* 25
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2014* 26
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2014* 27
Human papillomavirus (HPV) Associated Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2014* 29
GlobalData Methodology 119

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

Clinical Trial Management System Market by End-user, Delivery Mode, Type, Component - Global Forecast to 2021

  • $ 5650
  • Industry report
  • August 2016
  • by MarketsandMarkets

The global clinical trial management system (CTMS) market is estimated to grow at a CAGR of 11.5% from 2016 to 2021, to reach USD 920.0 billion by 2021. The adoption of CTMS software is on the rise across ...

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

Contract Research Organizations Services Market by Type, Therapeutic Area, End User - Global Forecast to 2021

  • $ 5650
  • Industry report
  • October 2016
  • by MarketsandMarkets

The global CRO services market is estimated to grow at a CAGR of 7.4% from 2016 to 2021, to reach USD 41.86 billion by 2021 from USD 29.29 billion in 2016. Growth in this market is primarily attributed ...

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

Clinical Trial Management System (CTMS) - Global Market Outlook (2016-2022)

  • $ 4157
  • Industry report
  • November 2016
  • by Stratistics MRC

According to Stratistics MRC, the Global Clinical Trial Management System (CTMS) market is expected to grow from $493.58 million in 2015 to reach $1118.58 million by 2022 with a CAGR of 12.4%. Huge research ...


ref:plp2014

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.